v3.25.2
Share based compensation reserve - Director and Senior Management Share Awards (Details)
€ in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Jul. 10, 2025
Jul. 10, 2024
shares
Jul. 06, 2023
Apr. 30, 2024
shares
Jun. 30, 2025
EUR (€)
shares
Jun. 30, 2024
EUR (€)
shares
Dec. 31, 2024
shares
Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
New awards granted in the period (in shares) 49,092 36,738 35,082        
Awards vested and issued in period (in shares)   (35,082)     (23,118)    
Liabilities from share-based payment transactions (in shares)   11,964          
New awards granted in the period (in shares) 49,092 36,738 35,082        
Share based compensation reserve | Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share based payment charge | €         € 0.3 € 0.3  
Share based compensation reserve | Key management personnel of entity or parent              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share based payment charge | €         3.8 4.7  
Stock Vested During Period, Value, Restricted Stock Award, Gross1 | €         (12.2) (9.7)  
Share based compensation reserve | Key Management Personnel Of Entity Or Parent, Reclassification to tax liability              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Reclassification of awards for settlement of tax liabilities | €         € (4.9) € (3.6)  
Restricted shares              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         3,128,416 2,503,002 2,503,002
New awards granted in the period (in shares)         1,159,853 1,427,492  
Forfeitures in the period (in shares)         (324,575) (210,843)  
Number of other equity instruments expired in share-based payment arrangement           129,048  
Awards vested and issued in period (in shares)         (631,994) (476,552)  
Number of other equity instruments outstanding (in shares) at end of period         3,331,700 3,114,051 3,128,416
New awards granted in the period (in shares)         1,159,853 1,427,492  
Restricted shares | January 1, 2021              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Awards vested and issued in period (in shares)       (256,687)      
Liabilities from share-based payment transactions (in shares)       219,865      
Restricted shares | January 1, 2022              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Awards vested and issued in period (in shares)         (349,823)    
Liabilities from share-based payment transactions (in shares)         282,171    
Restricted shares | Other Awards              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Awards vested and issued in period (in shares)         (62,000)    
Restricted shares | January 1, 2021              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period           605,600 605,600
New awards granted in the period (in shares)           0  
Forfeitures in the period (in shares)           0  
Number of other equity instruments expired in share-based payment arrangement           129,048  
Number of other equity instruments outstanding (in shares) at end of period           0  
New awards granted in the period (in shares)           0  
Restricted shares | January 1, 2022              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         704,983 730,594 730,594
New awards granted in the period (in shares)         0 0  
Forfeitures in the period (in shares)         (148,989) (12,546)  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)         (555,994) (476,552)  
Number of other equity instruments outstanding (in shares) at end of period         0 718,048 704,983
New awards granted in the period (in shares)         0 0  
Restricted shares | Other Awards              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         441,991 163,000 163,000
New awards granted in the period (in shares)         62,000 252,991  
Forfeitures in the period (in shares)         (20,000) (14,000)  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)         (76,000)    
Number of other equity instruments outstanding (in shares) at end of period         407,991 401,991 441,991
New awards granted in the period (in shares)         62,000 252,991  
Restricted shares | January 1, 2023              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         922,250 1,003,808 1,003,808
New awards granted in the period (in shares)         0 0  
Forfeitures in the period (in shares)         (69,759) (74,821)  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)         0    
Number of other equity instruments outstanding (in shares) at end of period         852,491 928,987 922,250
New awards granted in the period (in shares)         0 0  
Performance and Restricted Stock | January 1, 2024              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         1,059,192 0 0
New awards granted in the period (in shares)         0 1,174,501  
Forfeitures in the period (in shares)         (71,935) (109,476)  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)         0    
Number of other equity instruments outstanding (in shares) at end of period         987,257 1,065,025 1,059,192
New awards granted in the period (in shares)         0 1,174,501  
Performance and Restricted Stock | January 1, 2025              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         0    
New awards granted in the period (in shares)         1,097,853    
Forfeitures in the period (in shares)         (13,892)    
Awards vested and issued in period (in shares)         0    
Number of other equity instruments outstanding (in shares) at end of period         1,083,961   0
New awards granted in the period (in shares)         1,097,853    
Performance share awards | January 1, 2024              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
New awards granted in the period (in shares)             1,193,261
New awards granted in the period (in shares)             1,193,261